• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经根治性手术切除及术后使用紫杉醇和卡铂化疗实现转移性子宫内膜癌肉瘤长期完全缓解

Long-Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin.

作者信息

Novin Kambiz, Shahrokh Soroush, Shahin Mohadese, Taghizadeh-Hesary Farzad

机构信息

Radiation Oncology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

出版信息

Cancer Rep (Hoboken). 2025 Sep;8(9):e70346. doi: 10.1002/cnr2.70346.

DOI:10.1002/cnr2.70346
PMID:40922694
Abstract

OBJECTIVE

To present a case of metastatic endometrial carcinosarcoma (ECS) with a long-term complete response to chemotherapy using a paclitaxel and carboplatin regimen.

CASE REPORT

A 47-year-old premenopausal woman was diagnosed with a large, advanced intrauterine tumor. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. Pathological assessment revealed a uterine mass with mesenchymal and epithelial components consistent with ECS, while the right ovarian tumor was identified as serous papillary carcinoma. The patient experienced a prolonged postoperative recovery period lasting 3 months. Staging workup later revealed recurrence of adnexal and pulmonary lesions, indicating metastasis. The patient received 6 cycles of postoperative chemotherapy consisting of paclitaxel and carboplatin, achieving complete remission that has persisted for 3 years since the initial diagnosis.

CONCLUSIONS

This case highlights the efficacy of postoperative chemotherapy using paclitaxel and carboplatin in the successful treatment of metastatic ECS.

摘要

目的

报告一例转移性子宫内膜癌肉瘤(ECS)患者,其采用紫杉醇和卡铂方案化疗后获得长期完全缓解。

病例报告

一名47岁绝经前女性被诊断为患有巨大的晚期子宫内肿瘤。她接受了全腹子宫切除术及双侧输卵管卵巢切除术。病理评估显示子宫肿物具有与ECS一致的间叶和上皮成分,而右侧卵巢肿瘤被确定为浆液性乳头状癌。患者术后恢复期延长,持续了3个月。后期分期检查显示附件和肺部病变复发,提示转移。患者接受了6个周期的术后化疗,化疗方案为紫杉醇和卡铂,自初次诊断以来已实现完全缓解并持续了3年。

结论

本病例突出了紫杉醇和卡铂术后化疗在成功治疗转移性ECS中的疗效。

相似文献

1
Long-Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin.经根治性手术切除及术后使用紫杉醇和卡铂化疗实现转移性子宫内膜癌肉瘤长期完全缓解
Cancer Rep (Hoboken). 2025 Sep;8(9):e70346. doi: 10.1002/cnr2.70346.
2
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit.紫杉醇与卡铂用于子宫癌肉瘤完全切除或最佳切除患者:日本子宫肉瘤研究组和东北妇科癌症治疗中心的一项II期试验
Int J Gynecol Cancer. 2015 Jan;25(1):92-7. doi: 10.1097/IGC.0000000000000302.
3
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.多柔比星治疗紫杉醇/卡铂治疗后进展的晚期或复发性子宫内膜癌:1995 年至 2009 年 Memorial Sloan-Kettering 癌症中心的经验。
Int J Gynecol Cancer. 2013 Jun;23(5):929-34. doi: 10.1097/IGC.0b013e3182915c20.
4
Lymphoepithelioma-like carcinoma with carcinosarcoma of the endometrium: a case report and literature review.子宫内膜淋巴上皮瘤样癌伴癌肉瘤:一例报告及文献复习
Front Immunol. 2025 Jul 21;16:1636575. doi: 10.3389/fimmu.2025.1636575. eCollection 2025.
5
The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.辅助治疗对早期子宫癌肉瘤女性患者生存及复发模式的影响:一项多机构研究
Int J Gynecol Cancer. 2016 Jan;26(1):141-8. doi: 10.1097/IGC.0000000000000561.
6
Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.新辅助每周卡铂和紫杉醇联合根治性子宫切除术治疗局部晚期宫颈癌:长期结果。
Int J Gynecol Cancer. 2010 May;20(4):611-6. doi: 10.1111/IGC.0b013e3181d80aa9.
7
The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.日本复发性子宫内膜癌的临床特征:化疗而非放疗作为术后辅助治疗。
Int J Gynecol Cancer. 2018 Oct;28(8):1616-1623. doi: 10.1097/IGC.0000000000001346.
8
Carboplatin-Paclitaxel versus Cisplatin-Ifosfamide in the treatment of uterine carcinosarcoma: a retrospective cohort study.卡铂-紫杉醇与顺铂-异环磷酰胺治疗子宫癌肉瘤的回顾性队列研究。
Int J Gynecol Cancer. 2014 Sep;24(7):1256-61. doi: 10.1097/IGC.0000000000000215.
9
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial.在ENGOT-EN6-NSGO/GOG3031/RUBY试验中,与单纯化疗相比,接受多斯塔利单抗联合化疗治疗的错配修复缺陷/微卫星高度不稳定的原发性晚期或复发性子宫内膜癌患者亚组的患者报告结局。
Int J Gynecol Cancer. 2025 Jun;35(6):101852. doi: 10.1136/ijgc-2024-005484. Epub 2025 Apr 19.
10
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.